BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 2026GuruFocus · 1 day ago
ImmunoForge to Showcase Proprietary Platform Technologies and Next-Generation Oncology & Phase 2 Clinical Pipelines at BIO-Europe 2026GuruFocus · 2 days ago
Cohen & Steers: 3 Key Takeaways for Long-Term InvestorsThe Motley Fool · 5 days ago
Zipalertinib Demonstrates Clinically Meaningful Intracranial Antitumor Activity in Patients with NSCLC with EGFR Exon 20 Insertion or Uncommon EGFR Mutations and Active CNS MetastasesBusiness Wire · 5 days ago
The Winners Inside SCHD - October 2026Seeking Alpha · 6 days ago
Lilly to showcase advances across its oncology pipeline at the 2026 European Society for Medical Oncology (ESMO) CongressGuruFocus · 6 days agoCohen & Steers, Inc. operates as a publicly traded holding company specializing in asset management. Through its various operating units, the firm delivers financial services to institutional investors, such as pension funds, university endowments, and charitable foundations. Its subsidiaries are tasked with managing bespoke client portfolios across equities, fixed income, multi-asset strategies, and commodities.
| Date | Est. | Actual | |
|---|---|---|---|
| Oct 15, 2026 | $0.89 | $0.89 | Beat |
| Jul 16, 2026 | $0.86 | $0.85 | Miss |
| Apr 16, 2026 | $0.81 | $0.79 | Miss |
| Jan 22, 2026 | $0.81 | $0.81 | Beat |
| Oct 16, 2025 | $0.78 | $0.81 | Beat |
| Jul 17, 2025 | $0.75 | $0.73 | Miss |